Adenovirus-mediated cytotoxicity of chronic lymphocytic leukemia cells

Blood

Volumn 94, Issue 10, 1999, Pages 3499-3508

  Medina, Daniel J ^b   Sheay, Wendy ^b   Goodell, Lauri ^b   Kidd, Pamela ^b   White, Eileen ^b   Rabson, Arnold B ^b   Strair, Roger K ^a  

^a RUTGERS CANCER INSTITUTE OF NEW JERSEY   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADENOVIRUS 5; ARTICLE; B LYMPHOCYTE; CELL VIABILITY; CHRONIC LYMPHATIC LEUKEMIA; CONTROLLED STUDY; CYTOTOXICITY; HUMAN; HUMAN CELL; LEUKEMIA CELL; PRIORITY JOURNAL; VIRUS ATTENUATION; VIRUS MUTANT; VIRUS RECOMBINANT; VIRUS REPLICATION;

ADENOVIRIDAE; ADENOVIRUS E1A PROTEINS; ADENOVIRUS E1B PROTEINS; ADENOVIRUS E2 PROTEINS; ANTINEOPLASTIC AGENTS; APOPTOSIS; B-LYMPHOCYTES; GENE DELETION; HELA CELLS; HEMATOPOIETIC STEM CELLS; HUMANS; LEUKEMIA, LYMPHOCYTIC, CHRONIC; TUMOR CELLS, CULTURED; VIRUS REPLICATION;

EID: 0033571341     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. Horwitz MS: Adenoviridae and their replication, in Fields BN, Knipe DM (ed): Virology. New York, NY, Raven, 1990, p 1679
2. White E, Grodzicker T, Stillman B: Mutations in the gene encoding the adenovirus early region 1B 19,000 molecular weight tumor antigen cause degradation of chromosomal DNA. J Virol 52:410, 1984
3. White E: Regulation of p53-dependent apoptosis by E1A and E1B. Curr Top Microbiol Immunol 199:33, 1995
4. Lucher LR: Abortive adenovirus infection and host range determinants. Curr Top Microbiol Immunol 199:119, 1995
5. Hall AR, Dix BR, O'Carroll SJ, Braithwaite AW: p53-Dependent cell death/apoptosis is required for a productive adenovirus infection. Nat Med 4:1068, 1998
6. Bischoff JR, Kim DH, Williams A, Heise C, Horn S, Munna M, Ng L, Nye JA, Sampson-Johannes A, Fattaey A, McCormick F: An adenovirus mutant that replicates selectively in P53-deficient human tumor cells. Science 274:373, 1996
7. Heise C, Sampson-Johannes A, Williams A, McCormick F, Von Hoff DD, Kim DH: ONYX-015, an E1B gene-attenuated adenovirus, causes tumor-specific cytolysis and anti-tumor efficacy that can be augmented by standard chemotherapy agents. Nat Med 3:639, 1997
8. INK4B, p53, and Rb genes in primary lymphoid malignancies. Blood 87:4949, 1996
9. Gaidano G, Newcomb EW, Gong JZ, Tassi V, Neri A, Cortelzzi A, Calori R, Baldini L, Dalla-Favera R: Analysis of alterations of oncogenes and tumor suppressor genes in chronic lymphocytic leukemia. Am J Pathol 144:1334, 1994
10. th International Workshop on Chronic Lymphocytic Leukemia. Hematol Cell Ther 39:S5, 1997
11. th International Workshop on Chronic Lymphocytic Leukemia. Hematol Cell Ther 39: S17, 1997
12. Silver L, Anderson CW: Interaction of human adenovirus sertype 2 with human lymphoid cells. Virology 165:377, 1988
13. Horvath J, Weber JM: Nonpermissivity of human peripheral blood lymphocytes to adenovirus type 2 infection. J Virol 62:341, 1988
14. Jones N, Shenk T: An adenovirus type 5 early gene function regulates expression of other viral genes. Proc Natl Acad Sci USA 76:3665, 1979
15. White E, Cipriani R, Sabbatini P, Demon A: Adenovirus E1B 19-kilodalton protein overcomes the cytotoxicity of E1A proteins. J Virol 65:2968, 1991
16. Chiou SK, White E: p300 Binding by E1A cosegregates with p53 induction but is dispensable for apoptosis. J Virol 71:3515, 1997
17. Klessig DF, Brough DE, Cleghon V: Introduction, stable integration, and controlled expression of a chimeric adenovirus gene whose product is toxic to the recipient human cell. Mol Cell Biol 4:1354, 1984
18. Hsiung GD: Hsiung's Diagnostic Virology: As Illustrated by Light and Electron Microscopy. New Haven, CT, Yale, 1994
19. Pilder S, Logan J, Shenk T: Deletion of the gene encoding the adenovirus 5 early region 1B 21,000-molecular weight polypeptide leads to degradation of viral and host cell DNA. J Virol 52:564, 1984
20. Debbas M, White E: Wild-type p53 mediates apoptosis by E1A, which is inhibited by E1B. Genes Dev 7:546, 1993
21. Banchereau J, De Paoli P, Valle A, Garcia E, Rousset F: Long term human B-cell lines dependent upon interleukin-4 and anti-CD40. Science 251:70, 1991
22. Johnson PWM, Watt SM, Betts DR, Davies D, Jordan S, Nortyon AJ, Lister TA: Isolated follicular lymphoma cells are resistant to apoptosis and can be grown in vitro in the CD40-stromal cell system. Blood 82:1848, 1993
23. Buske C, Twiling A, Gogowski G, Schreiber K, Feuring-Buske M, Wulf GG, Hiddemann W, Wormann B: In vitro activation of low grade non-Hodgkin's lymphoma by murine fibroblasts, IL-4, anti-CD40 antibodies and the soluble CD40 ligand. Leukemia 11:1862, 1997
24. Samuelson AV, Lowe SW: Selective induction of p53 and chemosensitivity in RB-deficients cells by E1A mutants unable to bind the RB-related proteins. Proc Natl Acad Sci USA 94:12094, 1997
25. ARF tumor suppressor. Genes Dev 12:2434, 1998
26. Querido E, Teodoro JG, Branton PE: Accumulation of p53 induced by the adenovirus E1A protein requires regions involved in the induction of DNA synthesis. J Virol 71:3526, 1997
27. Thomas A, White E: Suppression of the p300-dependent mdm2 negative-feedback loop induces the p53 apoptotic function. Genes Dev 12:1975, 1998
28. Lowe S, Ruley HE: Stabilization of the p53 tumor suppressor gene is induced by adenovirus ela and accompanies apoptosis. Genes Dev 7:535, 1993
29. Marcellus RC, Lavoie JN, Boivin D, Shore GC, Ketner G, Branton PE: The early region 4 orf4 of human adenovirus type 5 induces p53-independent cell death by apoptosis. J Virol 72:7144, 1998
30. Shtrichman R, Kleinberger T: Adenovirus type 5 E4 open reading frame 4 protein induces apoptosis in transformed cells. J Virol 72:2975, 1998
31. Watanabe T, Kuszynski C, Ino K, Heimann DG, Shepard HM, Yasui Y, Maneval DC, Talmadge JE: Gene transfer into human bone marrow hematopoietic cells mediatd by adenovirus vectors. Blood 87:5032, 1996
32. Seth P, Katayose D, Li Z, Kim M, Wersto R, Craig C, Shanmugam N, Ohri E, Mudahar B, Rakkar AN, Kodali P, Cowan K: A recombinant adenovirus expressing wild type p53 induces apoptosis in drug-resistant human breast cancer cells: A gene therapy approach for drug resistant cancers. Cancer Gene Ther 4:383, 1997
33. Chen L, Pulsipher M, Chen D, Sieff C, Elias A, Fine HA, Kufe DW: Selective transgene expression for detection and elimination of contaminating carcinoma cells in hematopoietic stem cell sources. J Clin Invest 98:2539, 1996
34. Neering SJ, Hardy SF, Minamoto D, Spratt SK, Jordan CT: Transduction of primitive human hematopoietic cells with recombinant adenoviruses. Blood 88:1147, 1996
35. Teoh G, Chen L, Urashima M, Tai Y-T, Celi LA, Chen D, Chauhan D, Ogata A, Finberg RW, Webb IJ, Kufe DW, Anderson KC: Adenovirus-vector based purging of multiple myeloma cells. Blood 92:4591, 1998
36. Garcia-Sanchez F, Pizzorno G, Fu SQ, Nanakorn T, Krause DS, Liang J, Adams E, Leffert JJ, Yin LH, Cooperberg MR, Hanania E, Wang WL, Won JH, Peng XY, Cote R, Brown R, Burtness B, Giles R, Crystal R, Deisseroth AB: Cytosine deaminase adenoviral vector and 5-fluorocytosine selectively reduce breast cancer cells 1 million-fold when they contaminate hematopoietic cells: A potential purging method for autologous transplantation. Blood 92:672, 1998
37. Frey BM, Hackett NR, Bergelson JM, Finberg R, Crystal RG, Moore MAS, Raffi S: High efficiency gene transfer into ex vivo expanded human hematopoietic progenitors and precursor cells by adenovirus vectors. Blood 91:2781, 1998
38. Takahashi T, Yamada K, Tanaka T, Kumano K, Kurokawa M, Takahashi T, Hirano N, Honda H, Chiba S, Tsuji K, Yazaki Y, Nakahata T, Hirai H: A potential molecular approach to ex vivo hematopoietic expansion with a recombinant epidermal growth factor receptor-expressing adenovirus vector. Blood 91:4509, 1998